
EADV 2024
Drug Survival in Patients with Atopic Dermatitis: Dupilumab Vs Upadacitinib
This study was presented at the 33rd EADV Congress 2024 by Drs Carolina Montero- Vilchez et al from the Virgen

This study was presented at the 33rd EADV Congress 2024 by Drs Carolina Montero- Vilchez et al from the Virgen

This Case report was presented at the 33rd EADV Congress 2024 by Drs Letícia Scattone et al from the Complexo

This study was presented at the 33rd EADV Congress 2024 by Drs Serena Lambo et al from the University of

This study was presented at the 33rd EADV Congress 2024 by Drs Kilian Eyerich et al from the University of

A slew of sessions were presented on Wednesday September 25th at the 33rd EADV Congress 2024 on new drugs and